Medcare Royal Speciality Hospital In Dubai Transforming Lives Of Kids With Rare Genetic Diseases

In the heart of Dubai, Medcare Royal Speciality Hospital Al Qusais is pioneering advancements in the treatment of rare genetic disorders, such as Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD), drawing patients globally.

This initiative is part of Dubai's broader vision to become a global center for medical innovation and excellence, particularly in the arena of gene therapy. Located near Dubai International Airport, the hospital has become a beacon for families seeking life-altering treatments for conditions that, until recently, had limited options.

Medcare's commitment to excellence in pediatric neurology and gene-based therapies has made it a destination of choice for families, especially from Turkiye where the prevalence of SMA is significantly higher than the global average. The hospital's sophisticated facilities and holistic approach to treatment have established it as a Centre of Excellence in gene disorders, serving not just the UAE but also the MENA and Asia-Pacific regions. With over 3,000 people living with SMA in Turkiye and around 150 new cases diagnosed annually, the need for such specialised care is evident.

Under the guidance of Dr. Vivek Mundada, a British Board-certified Consultant Paediatric Neurologist, Medcare Royal Speciality Hospital has achieved significant milestones in treating these complex genetic conditions. Offering a groundbreaking one-time gene therapy that targets the underlying cause of the disease, Medcare has improved the lives of many, marking a departure from traditional treatments that necessitate ongoing spinal injections.

"Dubai is becoming a center of medical innovation, and Medcare is proud to be leading that movement, especially in the field of rare genetic diseases," Dr. Mundada stated. "Through our comprehensive, patient-centered care model, we are transforming outcomes for children who previously had limited treatment options."

The hospital's approach is comprehensive, incorporating a multidisciplinary team of specialists in neurology, pulmonology, orthopaedics, and more, ensuring that patients receive the best possible care. This level of care extends beyond the hospital stay, with continuous follow-up care for international patients even after they return home.

The stories of Mirha and Elif Bade, who underwent successful gene therapy at Medcare, underscore the life-changing impact of these treatments. Mirha, diagnosed with SMA shortly after birth, and Elif Bade, treated at just 2 years old, have both shown remarkable improvements, thriving without the need for additional support.

The gratitude expressed by the parents of Mirha highlights the profound effect of Medcare's work: "We cannot express enough gratitude to Dr. Mundada and the Medcare team. Thanks to the expert and compassionate care in Dubai, our daughter has been given a new lease on life."